Cohort Studymoderate evidence
Population-level benefits of correctional medications for opioid use disorder.
Journal of substance use and addiction treatment·September 12, 2026·PMID 42731697
Why it mattersIncarcerated individuals face a markedly elevated risk of fatal opioid overdose after release, and correctional settings are a critical but underutilized intervention point. This study provides strong quasi-experimental evidence that comprehensive MOUD access during incarceration can reduce overdose deaths at the population level, with benefits extending beyond those who directly receive medication.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled